Homegrown COVID-19 pill gets regulatory approval
By Wang Xiaoyu |
chinadaily.com.cn |
Updated: 2022-07-25 19:48
Share
Share - WeChat
China's top drug regulator said on Monday it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19.
Azvudine, developed by Genuine Biotech Co Ltd based in Henan province, was first approved to treat HIV/AIDS patients on July 20 last year, according to the National Medical Products Administration.
The approval clears the way for the pill to be used for adults with moderate COVID-19 symptoms, the administration said in a notice released on its official website.
- Cargo, fishing vessels collide in Bohai Sea, search for missing underway
- China's first 8K space film SHENZHOU 13 premieres in Shanghai
- Flags spotlight Hebei's enduring war legacy
- Harbin Institute of Technology opens China-SCO doctoral training center
- Xi extends congratulations to plenary session of China-Russia friendship committee
- China unveils asteroid defense mission plan
